About
Decoy Therapeutics
DCOY.US
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs.
Profile
- Company Name
- Decoy Therapeutics Inc.
- Market
- NasdaqCM
- Founded
- --
- Industry
- --
- Fiscal Year End
- December 31
- Website
- decoytx.com